Stay updated with breaking news from Kinarus ag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Kinarus further strengthens its leadership with two reputed industry experts Kinarus AG, Dr. Hari Kumar s long career took him from Roche to Eisai Ltd where he served as European Marketing Director. He returned to Roche as Global Head of Transplant Immunosuppressives. He subsequently moved to Amira Pharmaceuticals Inc. in 2007 as Chief Business Officer before becoming Chief Executive Officer of Adheron Therapeutics Inc.? In his career, Dr. Kumar oversaw the launch of the immunosuppressive, CellCept(R), the Alzheimer s drug, Aricept(R) and the gastric ulcer drug, Aciphex(R). At Amira, Dr. Kumar led the process that resulted in its acquisition by Bristol Myers Squibb in 2011. He also navigated the acquisition of Adheron Therapeutics by Roche, in his role as CEO/ Board member. These transactions have delivered over a billion dollars in returns to investors. ....